SCHEMBL32688138

SCHEMBL32688138

N#Cc1c(-c2ccc(C(=O)O)cc2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ACMSD Q8TDX5 5/20 0.41
▸ IKBKB O14920 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ HSD11B1 P28845 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688247 0.90 ACMSD (0.44) KMT2AALDH1A1HPGDACMSDIKBKB
SCHEMBL32688056 0.88 MET (0.41) KMT2AALDH1A1HPGDKDM4EMEN1
SCHEMBL32688192 0.84 ALDH1A1 (0.41) KMT2AALDH1A1HPGDACMSDKDM4E
SCHEMBL32687986 0.84 KMT2A (0.39) KMT2AALDH1A1HPGDACMSDKDM4E
SCHEMBL32688004 0.84 KMT2A (0.38) KMT2AALDH1A1HPGDKDM4EMEN1
SCHEMBL32688271 0.81 ALDH1A1 (0.42) KMT2AALDH1A1HPGDACMSDKDM4E
SCHEMBL32688262 0.81 GRK6 (0.37) ADORA3ADORA2AADORA2BADORA1HSD11B1
SCHEMBL32688038 0.80 ACMSD (0.45) KMT2AALDH1A1HPGDACMSDKDM4E
SCHEMBL32688132 0.78 CXCR2 (0.36) KMT2AALDH1A1HPGDKDM4ETSHR
SCHEMBL32688070 0.78 ACMSD (0.47) KMT2AACMSDMEN1POLBADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KMT2A 3400/4885ALDH1A1 290/4885HPGD 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback